nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Euphoric mood—Floxuridine—stomach cancer	0.0204	0.0532	CcSEcCtD
Trihexyphenidyl—Dry skin—Floxuridine—stomach cancer	0.0158	0.0412	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Methotrexate—stomach cancer	0.0155	0.0403	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Capecitabine—stomach cancer	0.0125	0.0326	CcSEcCtD
Trihexyphenidyl—Drowsiness—Mitomycin—stomach cancer	0.0104	0.0272	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methotrexate—stomach cancer	0.00933	0.0243	CcSEcCtD
Trihexyphenidyl—Confusional state—Floxuridine—stomach cancer	0.00855	0.0223	CcSEcCtD
Trihexyphenidyl—Vision blurred—Mitomycin—stomach cancer	0.00768	0.02	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Floxuridine—stomach cancer	0.00699	0.0182	CcSEcCtD
Trihexyphenidyl—Memory impairment—Capecitabine—stomach cancer	0.00691	0.018	CcSEcCtD
Trihexyphenidyl—Blindness—Epirubicin—stomach cancer	0.00682	0.0178	CcSEcCtD
Trihexyphenidyl—Confusional state—Mitomycin—stomach cancer	0.00671	0.0175	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Fluorouracil—stomach cancer	0.00666	0.0174	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—stomach cancer	0.00631	0.0164	CcSEcCtD
Trihexyphenidyl—Asthenia—Floxuridine—stomach cancer	0.00608	0.0158	CcSEcCtD
Trihexyphenidyl—Somnolence—Mitomycin—stomach cancer	0.00591	0.0154	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Mitomycin—stomach cancer	0.00548	0.0143	CcSEcCtD
Trihexyphenidyl—Vomiting—Floxuridine—stomach cancer	0.00539	0.014	CcSEcCtD
Trihexyphenidyl—Rash—Floxuridine—stomach cancer	0.00535	0.0139	CcSEcCtD
Trihexyphenidyl—Dermatitis—Floxuridine—stomach cancer	0.00534	0.0139	CcSEcCtD
Trihexyphenidyl—Headache—Floxuridine—stomach cancer	0.00531	0.0138	CcSEcCtD
Trihexyphenidyl—Dry skin—Fluorouracil—stomach cancer	0.00516	0.0134	CcSEcCtD
Trihexyphenidyl—Nausea—Floxuridine—stomach cancer	0.00504	0.0131	CcSEcCtD
Trihexyphenidyl—Asthenia—Mitomycin—stomach cancer	0.00477	0.0124	CcSEcCtD
Trihexyphenidyl—Weight decreased—Irinotecan—stomach cancer	0.0046	0.012	CcSEcCtD
Trihexyphenidyl—Dizziness—Mitomycin—stomach cancer	0.0044	0.0115	CcSEcCtD
Trihexyphenidyl—Vomiting—Mitomycin—stomach cancer	0.00423	0.011	CcSEcCtD
Trihexyphenidyl—Rash—Mitomycin—stomach cancer	0.00419	0.0109	CcSEcCtD
Trihexyphenidyl—Dermatitis—Mitomycin—stomach cancer	0.00419	0.0109	CcSEcCtD
Trihexyphenidyl—Headache—Mitomycin—stomach cancer	0.00417	0.0109	CcSEcCtD
Trihexyphenidyl—Nausea—Mitomycin—stomach cancer	0.00395	0.0103	CcSEcCtD
Trihexyphenidyl—Dry skin—Docetaxel—stomach cancer	0.00372	0.0097	CcSEcCtD
Trihexyphenidyl—Dry skin—Capecitabine—stomach cancer	0.00361	0.00939	CcSEcCtD
Trihexyphenidyl—Vision blurred—Fluorouracil—stomach cancer	0.0032	0.00832	CcSEcCtD
Trihexyphenidyl—Weight decreased—Docetaxel—stomach cancer	0.00318	0.00828	CcSEcCtD
Trihexyphenidyl—Weight decreased—Capecitabine—stomach cancer	0.00308	0.00801	CcSEcCtD
Trihexyphenidyl—Confusional state—Irinotecan—stomach cancer	0.00291	0.00759	CcSEcCtD
Trihexyphenidyl—Confusional state—Fluorouracil—stomach cancer	0.00279	0.00727	CcSEcCtD
Trihexyphenidyl—Tachycardia—Fluorouracil—stomach cancer	0.0027	0.00703	CcSEcCtD
Trihexyphenidyl—Somnolence—Irinotecan—stomach cancer	0.00257	0.00669	CcSEcCtD
Trihexyphenidyl—Dry skin—Epirubicin—stomach cancer	0.00251	0.00654	CcSEcCtD
Trihexyphenidyl—Constipation—Irinotecan—stomach cancer	0.00247	0.00643	CcSEcCtD
Trihexyphenidyl—Somnolence—Fluorouracil—stomach cancer	0.00246	0.00641	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Irinotecan—stomach cancer	0.00238	0.0062	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—stomach cancer	0.00232	0.00605	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Fluorouracil—stomach cancer	0.00228	0.00594	CcSEcCtD
Trihexyphenidyl—Drowsiness—Methotrexate—stomach cancer	0.00226	0.00588	CcSEcCtD
Trihexyphenidyl—Vision blurred—Capecitabine—stomach cancer	0.00223	0.00582	CcSEcCtD
Trihexyphenidyl—Weight decreased—Epirubicin—stomach cancer	0.00214	0.00558	CcSEcCtD
Trihexyphenidyl—Drowsiness—Epirubicin—stomach cancer	0.00211	0.0055	CcSEcCtD
Trihexyphenidyl—Asthenia—Irinotecan—stomach cancer	0.00207	0.0054	CcSEcCtD
Trihexyphenidyl—Confusional state—Docetaxel—stomach cancer	0.00201	0.00524	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—stomach cancer	0.00198	0.00516	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—stomach cancer	0.00195	0.00509	CcSEcCtD
Trihexyphenidyl—Confusional state—Capecitabine—stomach cancer	0.00195	0.00508	CcSEcCtD
Trihexyphenidyl—Tachycardia—Docetaxel—stomach cancer	0.00195	0.00508	CcSEcCtD
Trihexyphenidyl—Dizziness—Irinotecan—stomach cancer	0.00191	0.00498	CcSEcCtD
Trihexyphenidyl—Tachycardia—Capecitabine—stomach cancer	0.00189	0.00492	CcSEcCtD
Trihexyphenidyl—Vomiting—Irinotecan—stomach cancer	0.00184	0.00478	CcSEcCtD
Trihexyphenidyl—Dizziness—Fluorouracil—stomach cancer	0.00183	0.00477	CcSEcCtD
Trihexyphenidyl—Rash—Irinotecan—stomach cancer	0.00182	0.00474	CcSEcCtD
Trihexyphenidyl—Dermatitis—Irinotecan—stomach cancer	0.00182	0.00474	CcSEcCtD
Trihexyphenidyl—Headache—Irinotecan—stomach cancer	0.00181	0.00471	CcSEcCtD
Trihexyphenidyl—Somnolence—Docetaxel—stomach cancer	0.00178	0.00462	CcSEcCtD
Trihexyphenidyl—Vomiting—Fluorouracil—stomach cancer	0.00176	0.00458	CcSEcCtD
Trihexyphenidyl—Rash—Fluorouracil—stomach cancer	0.00174	0.00454	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fluorouracil—stomach cancer	0.00174	0.00454	CcSEcCtD
Trihexyphenidyl—Headache—Fluorouracil—stomach cancer	0.00173	0.00451	CcSEcCtD
Trihexyphenidyl—Nausea—Irinotecan—stomach cancer	0.00172	0.00447	CcSEcCtD
Trihexyphenidyl—Constipation—Docetaxel—stomach cancer	0.00171	0.00445	CcSEcCtD
Trihexyphenidyl—Vision blurred—Methotrexate—stomach cancer	0.00166	0.00433	CcSEcCtD
Trihexyphenidyl—Constipation—Capecitabine—stomach cancer	0.00165	0.00431	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Docetaxel—stomach cancer	0.00165	0.00429	CcSEcCtD
Trihexyphenidyl—Nausea—Fluorouracil—stomach cancer	0.00164	0.00428	CcSEcCtD
Trihexyphenidyl—Tension—Epirubicin—stomach cancer	0.00162	0.00422	CcSEcCtD
Trihexyphenidyl—Nervousness—Epirubicin—stomach cancer	0.0016	0.00418	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Capecitabine—stomach cancer	0.00159	0.00415	CcSEcCtD
Trihexyphenidyl—Vision blurred—Epirubicin—stomach cancer	0.00156	0.00405	CcSEcCtD
Trihexyphenidyl—Agitation—Epirubicin—stomach cancer	0.00152	0.00395	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—stomach cancer	0.0015	0.0039	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—stomach cancer	0.00148	0.00386	CcSEcCtD
Trihexyphenidyl—Confusional state—Methotrexate—stomach cancer	0.00145	0.00378	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—stomach cancer	0.00144	0.00375	CcSEcCtD
Trihexyphenidyl—Asthenia—Docetaxel—stomach cancer	0.00143	0.00373	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—stomach cancer	0.0014	0.00366	CcSEcCtD
Trihexyphenidyl—Asthenia—Capecitabine—stomach cancer	0.00139	0.00361	CcSEcCtD
Trihexyphenidyl—Confusional state—Epirubicin—stomach cancer	0.00136	0.00354	CcSEcCtD
Trihexyphenidyl—Dizziness—Docetaxel—stomach cancer	0.00132	0.00344	CcSEcCtD
Trihexyphenidyl—Tachycardia—Epirubicin—stomach cancer	0.00131	0.00342	CcSEcCtD
Trihexyphenidyl—Somnolence—Methotrexate—stomach cancer	0.00128	0.00333	CcSEcCtD
Trihexyphenidyl—Dizziness—Capecitabine—stomach cancer	0.00128	0.00333	CcSEcCtD
Trihexyphenidyl—Vomiting—Docetaxel—stomach cancer	0.00127	0.00331	CcSEcCtD
Trihexyphenidyl—Rash—Docetaxel—stomach cancer	0.00126	0.00328	CcSEcCtD
Trihexyphenidyl—Dermatitis—Docetaxel—stomach cancer	0.00126	0.00328	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—stomach cancer	0.00126	0.00327	CcSEcCtD
Trihexyphenidyl—Headache—Docetaxel—stomach cancer	0.00125	0.00326	CcSEcCtD
Trihexyphenidyl—Vomiting—Capecitabine—stomach cancer	0.00123	0.0032	CcSEcCtD
Trihexyphenidyl—Rash—Capecitabine—stomach cancer	0.00122	0.00318	CcSEcCtD
Trihexyphenidyl—Dermatitis—Capecitabine—stomach cancer	0.00122	0.00317	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—stomach cancer	0.00122	0.00317	CcSEcCtD
Trihexyphenidyl—Headache—Capecitabine—stomach cancer	0.00121	0.00315	CcSEcCtD
Trihexyphenidyl—Somnolence—Epirubicin—stomach cancer	0.0012	0.00312	CcSEcCtD
Trihexyphenidyl—Nausea—Docetaxel—stomach cancer	0.00119	0.00309	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methotrexate—stomach cancer	0.00119	0.00309	CcSEcCtD
Trihexyphenidyl—Constipation—Epirubicin—stomach cancer	0.00115	0.003	CcSEcCtD
Trihexyphenidyl—Nausea—Capecitabine—stomach cancer	0.00115	0.00299	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Epirubicin—stomach cancer	0.00111	0.00289	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—stomach cancer	0.00111	0.00289	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—stomach cancer	0.00107	0.00278	CcSEcCtD
Trihexyphenidyl—Asthenia—Methotrexate—stomach cancer	0.00103	0.00269	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—stomach cancer	0.00103	0.00268	CcSEcCtD
Trihexyphenidyl—Asthenia—Epirubicin—stomach cancer	0.000967	0.00252	CcSEcCtD
Trihexyphenidyl—Dizziness—Methotrexate—stomach cancer	0.000952	0.00248	CcSEcCtD
Trihexyphenidyl—Vomiting—Methotrexate—stomach cancer	0.000915	0.00238	CcSEcCtD
Trihexyphenidyl—Rash—Methotrexate—stomach cancer	0.000908	0.00236	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methotrexate—stomach cancer	0.000907	0.00236	CcSEcCtD
Trihexyphenidyl—Headache—Methotrexate—stomach cancer	0.000902	0.00235	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxorubicin—stomach cancer	0.000894	0.00233	CcSEcCtD
Trihexyphenidyl—Dizziness—Epirubicin—stomach cancer	0.000891	0.00232	CcSEcCtD
Trihexyphenidyl—Vomiting—Epirubicin—stomach cancer	0.000857	0.00223	CcSEcCtD
Trihexyphenidyl—Nausea—Methotrexate—stomach cancer	0.000855	0.00223	CcSEcCtD
Trihexyphenidyl—Rash—Epirubicin—stomach cancer	0.000849	0.00221	CcSEcCtD
Trihexyphenidyl—Dermatitis—Epirubicin—stomach cancer	0.000849	0.00221	CcSEcCtD
Trihexyphenidyl—Headache—Epirubicin—stomach cancer	0.000844	0.0022	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—stomach cancer	0.000824	0.00215	CcSEcCtD
Trihexyphenidyl—Nausea—Epirubicin—stomach cancer	0.0008	0.00208	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—stomach cancer	0.000793	0.00206	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—stomach cancer	0.000786	0.00205	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—stomach cancer	0.000785	0.00204	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—stomach cancer	0.000781	0.00203	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—stomach cancer	0.00074	0.00193	CcSEcCtD
Trihexyphenidyl—CHRM2—Signaling Pathways—ANXA1—stomach cancer	0.000159	0.000258	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRB1—stomach cancer	0.000156	0.000253	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRB1—stomach cancer	0.000156	0.000252	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FYN—stomach cancer	0.000155	0.000252	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRB1—stomach cancer	0.000154	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCL8—stomach cancer	0.000153	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FGFR2—stomach cancer	0.000152	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RPS6—stomach cancer	0.000149	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RPS6—stomach cancer	0.000149	0.000241	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPP2R1A—stomach cancer	0.000148	0.00024	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RPS6—stomach cancer	0.000147	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCL8—stomach cancer	0.000147	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	0.000147	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	0.000146	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	0.000146	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	0.000146	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FGFR2—stomach cancer	0.000146	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTP1—stomach cancer	0.000145	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	0.000145	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	0.000144	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—HMOX1—stomach cancer	0.000143	0.000232	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IRS2—stomach cancer	0.000139	0.000226	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HBEGF—stomach cancer	0.000137	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HBEGF—stomach cancer	0.000137	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HBEGF—stomach cancer	0.000135	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CAV1—stomach cancer	0.000135	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOA1—stomach cancer	0.000135	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TYMS—stomach cancer	0.000135	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IRS2—stomach cancer	0.000133	0.000216	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTM1—stomach cancer	0.000133	0.000216	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6R—stomach cancer	0.00013	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6R—stomach cancer	0.00013	0.000211	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	0.00013	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CAV1—stomach cancer	0.000129	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	0.000129	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOA1—stomach cancer	0.000129	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6R—stomach cancer	0.000129	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PRKCB—stomach cancer	0.000129	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6ST—stomach cancer	0.000128	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	0.000128	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRB2—stomach cancer	0.000126	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRB2—stomach cancer	0.000126	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ERCC2—stomach cancer	0.000125	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRB2—stomach cancer	0.000125	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	0.000124	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	0.000123	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PRKCB—stomach cancer	0.000123	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APC—stomach cancer	0.000123	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6ST—stomach cancer	0.000123	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	0.000122	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—MAPK3—stomach cancer	0.000118	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APC—stomach cancer	0.000118	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—RHOA—stomach cancer	0.000118	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MTHFR—stomach cancer	0.000118	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—RHOA—stomach cancer	0.000117	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—RHOA—stomach cancer	0.000116	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SMAD4—stomach cancer	0.000115	0.000187	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SMAD4—stomach cancer	0.000115	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6R—stomach cancer	0.000114	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	0.000114	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SMAD4—stomach cancer	0.000114	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	0.000113	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—MAPK3—stomach cancer	0.000113	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	0.000112	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—MAPK1—stomach cancer	0.000112	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EGFR—stomach cancer	0.000112	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6R—stomach cancer	0.000109	0.000178	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FYN—stomach cancer	0.000109	0.000177	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FYN—stomach cancer	0.000109	0.000177	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CAV1—stomach cancer	0.000109	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOA1—stomach cancer	0.000108	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FYN—stomach cancer	0.000108	0.000175	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—MAPK1—stomach cancer	0.000107	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—stomach cancer	0.000107	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—PIK3CA—stomach cancer	0.000107	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SERPINE1—stomach cancer	0.000107	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—KRAS—stomach cancer	0.000106	0.000172	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	0.000103	0.000168	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RHOA—stomach cancer	0.000103	0.000167	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	0.000103	0.000167	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—PIK3CA—stomach cancer	0.000103	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGFR2—stomach cancer	0.000103	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SERPINE1—stomach cancer	0.000102	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGFR2—stomach cancer	0.000102	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOS3—stomach cancer	0.000102	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	0.000102	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—KRAS—stomach cancer	0.000101	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGFR2—stomach cancer	0.000101	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RHOA—stomach cancer	9.88e-05	0.00016	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOS3—stomach cancer	9.78e-05	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PIK3CA—stomach cancer	9.72e-05	0.000158	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ERBB2—stomach cancer	9.55e-05	0.000155	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARG—stomach cancer	9.54e-05	0.000155	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IRS2—stomach cancer	9.39e-05	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IRS2—stomach cancer	9.36e-05	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PIK3CA—stomach cancer	9.31e-05	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IRS2—stomach cancer	9.27e-05	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ERBB2—stomach cancer	9.14e-05	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CAV1—stomach cancer	9.1e-05	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOA1—stomach cancer	9.08e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CAV1—stomach cancer	9.07e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—stomach cancer	9.06e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOA1—stomach cancer	9.05e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRAS—stomach cancer	9e-05	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CAV1—stomach cancer	8.99e-05	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOA1—stomach cancer	8.97e-05	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1B—stomach cancer	8.84e-05	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—stomach cancer	8.67e-05	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCB—stomach cancer	8.66e-05	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCB—stomach cancer	8.64e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6ST—stomach cancer	8.63e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRAS—stomach cancer	8.62e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—stomach cancer	8.61e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6ST—stomach cancer	8.6e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—stomach cancer	8.58e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCB—stomach cancer	8.55e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6ST—stomach cancer	8.52e-05	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1B—stomach cancer	8.47e-05	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCND1—stomach cancer	8.44e-05	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—JUN—stomach cancer	8.42e-05	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APC—stomach cancer	8.29e-05	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APC—stomach cancer	8.27e-05	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—stomach cancer	8.25e-05	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NOS3—stomach cancer	8.21e-05	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—stomach cancer	8.19e-05	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APC—stomach cancer	8.19e-05	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1A—stomach cancer	8.16e-05	0.000132	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCND1—stomach cancer	8.08e-05	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—JUN—stomach cancer	8.06e-05	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK8—stomach cancer	7.97e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	7.94e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	7.92e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—stomach cancer	7.84e-05	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	7.84e-05	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1A—stomach cancer	7.82e-05	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6R—stomach cancer	7.7e-05	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6R—stomach cancer	7.68e-05	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK8—stomach cancer	7.63e-05	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6R—stomach cancer	7.6e-05	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	7.56e-05	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—stomach cancer	7.55e-05	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	7.53e-05	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—stomach cancer	7.53e-05	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—stomach cancer	7.51e-05	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	7.46e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—stomach cancer	7.46e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—stomach cancer	7.35e-05	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STAT3—stomach cancer	7.28e-05	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	7.22e-05	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	7.21e-05	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	7.2e-05	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	7.19e-05	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—KRAS—stomach cancer	7.14e-05	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	7.13e-05	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	7.12e-05	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—KRAS—stomach cancer	7.11e-05	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—KRAS—stomach cancer	7.04e-05	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—stomach cancer	7.04e-05	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STAT3—stomach cancer	6.97e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK3—stomach cancer	6.96e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RHOA—stomach cancer	6.96e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RHOA—stomach cancer	6.93e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOS3—stomach cancer	6.88e-05	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RHOA—stomach cancer	6.87e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOS3—stomach cancer	6.86e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOS3—stomach cancer	6.79e-05	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MYC—stomach cancer	6.77e-05	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK3—stomach cancer	6.66e-05	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK1—stomach cancer	6.62e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—stomach cancer	6.62e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	6.56e-05	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	6.54e-05	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MYC—stomach cancer	6.48e-05	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	6.47e-05	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ERBB2—stomach cancer	6.44e-05	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ERBB2—stomach cancer	6.42e-05	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ERBB2—stomach cancer	6.36e-05	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK1—stomach cancer	6.34e-05	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—stomach cancer	6.34e-05	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KRAS—stomach cancer	6.25e-05	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—stomach cancer	6.11e-05	9.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—stomach cancer	6.09e-05	9.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRAS—stomach cancer	6.07e-05	9.85e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRAS—stomach cancer	6.05e-05	9.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—stomach cancer	6.03e-05	9.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRAS—stomach cancer	5.99e-05	9.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KRAS—stomach cancer	5.99e-05	9.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	5.96e-05	9.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	5.94e-05	9.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	5.89e-05	9.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—stomach cancer	5.81e-05	9.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—stomach cancer	5.79e-05	9.4e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	5.74e-05	9.33e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—stomach cancer	5.73e-05	9.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCND1—stomach cancer	5.69e-05	9.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—JUN—stomach cancer	5.68e-05	9.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCND1—stomach cancer	5.67e-05	9.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—JUN—stomach cancer	5.66e-05	9.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCND1—stomach cancer	5.62e-05	9.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—JUN—stomach cancer	5.6e-05	9.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—stomach cancer	5.56e-05	9.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—stomach cancer	5.52e-05	8.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—stomach cancer	5.51e-05	8.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	5.5e-05	8.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	5.5e-05	8.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	5.49e-05	8.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—stomach cancer	5.45e-05	8.85e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	5.43e-05	8.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK8—stomach cancer	5.37e-05	8.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK8—stomach cancer	5.35e-05	8.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—stomach cancer	5.32e-05	8.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRAS—stomach cancer	5.31e-05	8.63e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK8—stomach cancer	5.3e-05	8.61e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRAS—stomach cancer	5.09e-05	8.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—stomach cancer	5.09e-05	8.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—stomach cancer	4.96e-05	8.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—stomach cancer	4.94e-05	8.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STAT3—stomach cancer	4.91e-05	7.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—stomach cancer	4.9e-05	7.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STAT3—stomach cancer	4.89e-05	7.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—stomach cancer	4.87e-05	7.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STAT3—stomach cancer	4.85e-05	7.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK3—stomach cancer	4.69e-05	7.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK3—stomach cancer	4.68e-05	7.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK3—stomach cancer	4.63e-05	7.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CA—stomach cancer	4.62e-05	7.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MYC—stomach cancer	4.56e-05	7.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MYC—stomach cancer	4.55e-05	7.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MYC—stomach cancer	4.5e-05	7.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK1—stomach cancer	4.46e-05	7.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—stomach cancer	4.46e-05	7.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK1—stomach cancer	4.45e-05	7.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—stomach cancer	4.45e-05	7.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK1—stomach cancer	4.41e-05	7.15e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—stomach cancer	4.41e-05	7.15e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KRAS—stomach cancer	4.22e-05	6.84e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KRAS—stomach cancer	4.2e-05	6.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KRAS—stomach cancer	4.16e-05	6.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	3.87e-05	6.29e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	3.86e-05	6.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	3.82e-05	6.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—stomach cancer	3.75e-05	6.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—stomach cancer	3.74e-05	6.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—stomach cancer	3.7e-05	6e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRAS—stomach cancer	3.58e-05	5.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRAS—stomach cancer	3.57e-05	5.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRAS—stomach cancer	3.54e-05	5.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—stomach cancer	3.43e-05	5.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—stomach cancer	3.42e-05	5.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—stomach cancer	3.39e-05	5.5e-05	CbGpPWpGaD
